BIO Livestock Summit

News

ARGUS LEADER– 09.13.16

SAB Biotherapeutics on Path to Human Clinical Trials

There are a few truly significant milestones in the life of a biomedical startup. One is gaining approval from the Food & Drug Administration, opening a path to market. But first comes another landmark moment: beginning human clinical trials.

That’s where Sioux Falls-based SAB Biotherapeutics finds itself after almost two decades of work. The company has started a phase one clinical trial for its human ...

A Polk Perspective: Florida's families depend on a healthy attitude toward biotech

As the mother of two teenage daughters, there's plenty for me to worry about. One growing concern, based on what I've seen over my 26-year career in agriculture, is what kind of future they're going to have if activists block advances in the application of biotechnology. Florida needs this technology to fight diseases in agriculture like citrus greening or in humans like the deadly Zika virus.

There’s No Panacea for the Zika Epidemic

Zika has hit Florida. At least 14 cases of infection with the mosquito-borne virus are now confirmed, with more certain to come, and federal health officials are warning against visiting the Miami neighborhood where transmission occurred. Meanwhile, top athletes in golf and cycling, citing reluctance to travel to a Zika-afflicted area, have opted out of the Rio Olympic Games that begin in Brazil on Friday.

GMOs lead the fight against Zika, Ebola and the next unknown pandemic

The shadow of the Zika virus hangs over the Rio Olympic Games, with visitors and even high-profile athletes citing worries about Zika as a reason to stay away (even if the risk is probably quite low). The public’s concerns are a striking example of the need to rapidly combat emerging infectious diseases. In the fight against Zika, public health experts have turned to what may sound like an unlikely ally: genetically modified organisms, or GMOs.

Biologist: Rabbits and Skunks Can Pass Bird Flu to Ducks

Much has been said about the genetically-engineered AquAdvantage® Salmon, and much of it has been wrong. In the interest of setting the record straight, the Alliance for Science interviewed Ron Stotish, chief executive officer of AquaBounty, at the recent BIO conference in San Francisco. In this video by Hannah Walker Smith, Stotish discusses the salmon’s safety, and how he got the first GE animal approved for human consumption. Stotish gives more detail on the regulatory process in this Q&A with Joan Conrow.

Upcoming Webinar: Antimicrobial Resistance in the Environment (Part 2 of 2)

This presentation will discuss findings of widespread antibiotic resistance in the environment. Massive amounts of human and animal waste applied to agricultural fields alter the global “resistome.” Wildlife never exposed to antibiotics harbor antibiotic resistant bacteria in their feces. The Human Microbiome project has found that microbial cells outnumber human cells by an estimated 10-fold, fundamentally changing our perceptions about health and disease. Taken together, the findings of antibiotic resistance in external and internal environments suggest that human antibiotic use has altered global microbial populations in ways that we do not fully understand. We are fast approaching a post antibiotic era. This presents challenges and opportunities and will require a One Health approach to succeed.

Upcoming Webinar: One Health and the Politics of Antibiotic Resistance (Part 1 of 2)

The rise of antibiotic resistant bacteria has created a crisis in medicine and veterinary medicine. The use of antibiotics as growth promoting agents in livestock has been a highly political issue. Europe approved avoparcin, a growth-promoting antibiotic, in the 1970’s. Its widespread use led to the rise of vancomycin resistant Enterococcus faecium (VRE). In contrast, the US has requested that its livestock producers voluntarily stop using antibiotic growth promoting agents. Using a One Health approach by integrating the perspectives of medicine/public health and veterinary medicine/agriculture, this presentation briefly compares and contrasts the EU versus the US experience regarding antibiotic use, antibiotic resistance, and livestock production.

Genus and Caribou Biosciences Announce Exclusive Collaboration for Leading CRISPR-Cas9 Gene Editing Technology in Livestock Species

Genus plc (LSE: GNS) (“Genus”), a global pioneer in animal genetics, and Caribou Biosciences, Inc. (“Caribou”), a leader in the revolutionary field of CRISPR-Cas gene editing, are pleased to announce a multi-year strategic collaboration where Genus receives a worldwide, exclusive license to Caribou’s leading CRISPR-Cas9 gene editing technology platform in certain livestock species. This is a significant move for Genus and marks the largest technology-driven alliance that Genus has made to date. The partnership positions Caribou at the forefront of an emerging market for which CRISPR-Cas9 could have profound benefits to animal welfare and society.

Biologist: Rabbits and Skunks Can Pass Bird Flu to Ducks

A government wildlife researcher has found that rabbits and skunks can become infected with the bird flu virus and shed it enough to infect ducks — offering scientists one more clue about how bird flu may move in the environment and spread between farms, the U.S. Department of Agriculture said.

Policy: Security Spending Must Cover Disease Outbreaks

The health emergency precipitated by the Zika virus is a salutary reminder: global preparedness for emerging pathogens with endemic or pandemic potential is crucial and needs an overhaul. These crises are not rare — Lassa fever, Ebola virus, Middle East respiratory syndrome, H1N1 influenza and severe acute respiratory syndrome (SARS) have surfaced in head-spinning succession over the past 10–15 years. Each emergence proves how woefully unprepared the global community is to deal with worldwide health emergencies that have deep societal and economic impact.

Senator Franken’s Legislative Director Ali Nouri accepted the award on his behalf during the AAVMC’s recent 50th Anniversary Gala ceremonies in Washington, D.C.

Senator Franken Honored with Charter “President’s Award for Meritorious Service"

The Association of American Veterinary Medical Colleges (AAVMC) recently awarded its first “President’s Award for Meritorious Service” to Senator Al Franken (D-Minnesota) in recognition of the leadership role he has taken on Capitol Hill in advancing One Health. One Health is broadly viewed as multiple health disciplines working together to attain optimal health for people, animals and our environment.

Senator Franken’s Legislative Director Ali Nouri accepted the award on his behalf during the AAVMC’s recent 50th Anniversary Gala ceremonies in Washington, D.C.

New Weapon to Fight Zika: The Mosquito

Every weekday at 7 a.m., a van drives slowly through the southeastern Brazilian city of Piracicaba carrying a precious cargo — mosquitoes. More than 100,000 of them are dumped from plastic containers out the van’s window, and they fly off to find mates.

But these are not ordinary mosquitoes. They have been genetically engineered to pass a lethal gene to their offspring, which die before they can reach adulthood. In small tests, this approach has lowered mosquito populations by 80 percent or more.

NAS Panel Tackles—and is Tackled by—Genome Editing in Animals

A 2-day National Academy of Sciences (NAS) workshop here last week exposed just how far scientists, ethicists, and regulators are from agreeing on the best way to move forward with genome editing in animals. Following on the heels of this month’s NAS summit on genome editing in humans, the workshop attracted much less attention, even though the work has more immediate regulatory and scientific implications. It also has the potential to shape how these technologies may one day be used in humans.

Genetically Engineered Salmon Approved for Consumption

Federal regulators on Thursday approved a genetically engineered salmon as fit for consumption, making it the first genetically altered animal to be cleared for American supermarkets and dinner tables.

The approval by the Food and Drug Administration caps a long struggle for AquaBounty Technologies, a small company that first approached the F.D.A. about approval in the 1990s. The agency made its initial determination that the fish would be safe to eat and for the environment more than five years ago.

This Scientist Might End Animal Cruelty—Unless GMO Hardliners Stop Him

Maybe you've watched the undercover video: A farmer presses a hot iron into the scalp of a wide-eyed calf, burning away tissue that is beginning to turn into horns. She writhes, moaning pathetically, and collapses in the dirt.

When Scott Fahrenkrug saw that footage, released by Mercy for Animals in 2010, it made him sick to his stomach. Most of the roughly 9 million dairy cows in the United States have been dehorned—with an iron, clippers, or caustic paste—to protect handlers and other cows. Fahrenkrug, then a professor in the department of animal science at the University of Minnesota, decided to do something to stop it. "I started talking to producers, and it became real clear to me that it wasn't just me being touchy-feely," he says. Dairy farmers told him they hated dehorning calves, and they were under pressure from animal welfare groups and customers, like General Mills and Nestlé, to phase it out.

Genetically Modified Mosquitoes Massively Reduce Dengue Fever Risk

Dengue fever is so excruciating that it is often called the “bone breaker,” causing severe pain in the joints and abdomen, vomiting, and circulatory system failure. It’s nearly impossible to treat, so the only way to cut down on incidences of the disease is to decrease the number of mosquitoes that carry it. One startling effective way to do that: genetically modifying mosquitos so their offspring won't survive. A year-long trial with genetically modified mosquitoes in northeast Brazil has been the most successful yet, reducing the population of the disease-carrying insects by 95 percent, according to a study published last week in PLOS Neglected Tropical Diseases.

Gene Editing Will Change Everything—Just Not All at One Time

From the discovery in the late 1980s by researchers at Osaka University of strange repeat DNA sequences sitting beside a gene in a common bacterium, to the frenzied deals and financings over CRISPR technology today, gene editing has taken firm hold in the worlds of basic and applied life science. In fact, the variety of gene-editing technologies goes way beyond CRISPR, and its commercial applications go beyond human therapeutics to encompass agriculture, both plants and animals, and a broad array of high-margin industrial products. In short, gene editing holds the promise of transforming the way R&D is conducted and products developed across major sectors of the global life science economy.

Conferences and Events:

BIO Livestock Summit

H1:

Animal Biotech Summit News

Advisory Committee

Tom Carrato, JD, Member & Principal Consultant, Creative Biotech Solutions, LLC

J. Thomas (“Tom”) Carrato, J.D. is an attorney and the principal of Creative Biotech Solutions, LLC, an agricultural technologies consulting firm. Tom is a globally recognized expert in strategic regulatory policy issues related to seed trait technologies, including agricultural biotechnology, with particular expertise and special emphasis on technology and product stewardship, freedom to operate, issues management, risk management, liability and redress, and regulatory capacity building. Tom is an expert facilitator and negotiator, with the demonstrated ability to work multi-laterally and in trade associations to facilitate the crafting of innovative and unique solutions to seemingly insurmountable regulatory, liability and commercial agricultural biotechnology policy issues for the benefit of his clients and of the industry as a whole. Tom is an expert on systems for post patent access to agricultural biotechnology and for response to damage to biological diversity. Tom has over 25 years experience working in trade associations to achieve critical policy objectives on behalf of industry.

Chase Crawford, DVM, Director, Antimicrobial Resistance Initiative

Dr. Chase A. Crawford joined the AAVMC in 2015 in a position jointly funded by the AAVMC and the Association of Public and Land Grant Universities (APLU). He leads the implementation of a series of remedial and control strategies and programs expected to emerge soon from the AAVMC/Association of Public and Land-grant Universities Task Force on Anti-Microbial Resistance.

Prior to his appointment, he conducted an AAAS Congressional Science and Technology Fellowship in the office of U.S. Senator Al Franken (D-MN). During that position, he was instrumental in supporting Franken’s initiatives in One Health, agriculture, energy and the environment.

Before the AAAS Fellowship, Chase served as a Human-Animal Interface Intern with the World Health Organization in Geneva, Switzerland, and prior to that, he conducted a Disease Intelligence Internship with the Food and Agriculture Organization of the United Nations (FAO) in Rome, Italy, where he focused on global zoonotic disease threats.

Chase earned his DVM degree from the Texas A&M University College of Veterinary Medicine & Biomedical Sciences, where he was awarded the Fred P. Jaggi Award for Outstanding proficiency in Veterinary Public Health. He also earned MS and BS degrees from Texas A&M.

Bernadette Dunham, DVM, PhD, Visiting Professor at Milken Institute School of Public Health, George Washington University

Bernadette Dunham, DVM, PhD, is currently a Visiting Professor with the Milken Institute School of Public Health at George Washington University where her focus is on One Health issues. Dunham served as Director of the Center for Veterinary Medicine (CVM) at the Food and Drug Administration (FDA) from 2008-2016. The Center regulates the manufacture and distribution of safe and effective drugs and food additives that will be given to animals, including animals from which human foods are derived, as well as companion animals and minor species. During her tenure at CVM Dunham also served as Deputy Director of CVM, Director of the Office of Minor Use and Minor Species Animal Drug Development, and Deputy Director of the Office of New Animal Drug Evaluation. From 1996-2012, Dunham was an Adjunct Professor in the Department of Biomedical Sciences and Pathobiology at the Virginia-Maryland Regional College of Veterinary Medicine. Prior to joining FDA in 2002, Dunham was Acting Director for the American Veterinary Medical Association's (AVMA) Governmental Relations Division in Washington, D.C. She also served as Director of Laboratory Animal Medicine and Adjunct Professor of Pharmacology at the State University of New York Health Science Center, Syracuse, N.Y. She participated in a post-doctoral residency program in the Department of Pathology at the N.Y. State College of Veterinary Medicine, Cornell University, Ithaca, N.Y., and was a research assistant professor at Boston University. Prior to returning to academia to pursue her Ph.D., Dunham was in private practice in Ontario, Canada. Dunham received the degree of Doctor of Veterinary Medicine from the Ontario Veterinary College at the University of Guelph, and a Ph.D. in cardiovascular physiology from Boston University.

Cassie Edgar, JD, Associate General Counsel, IP & Director, R&D Strategy, Genus Plc.

Cassie Edgar is Associate General Counsel, IP for Genus. She has 18 years of experience in the biotechnology industry with a focus on intellectual property, international regulatory law and complex licensing and litigation matters. Cassie joined Genus in September 2014 from Pioneer DuPont, where she served for 14 years in research, legal and management roles including IP Counsel, Sr. Regulatory Counsel, and Director in the Agricultural Biotechnology group. While at Pioneer, Cassie was an active member of BIO on the plant policy committee and post-patent task force, working on a mechanism to ensure access to regulatory data for biotech traits after patent expiration. She holds a B.S. in Molecular Genetics from The Ohio State University, a M.S. from North Carolina State University, and obtained her law degree from Drake University.

Kipp Erickson, PhD, Vice President, Technology & Commercialization, Intrexon Corporation

Barbara Glenn, PhD, Chief Executive Officer, National Association of State Departments of Agriculture (NASDA)

Dr. Barbara Glenn recently joined the National Association of State Departments of Agriculture (NASDA) as CEO on August 18, 2014.

Dr. Glenn is a scientist with decades of experience as a policy researcher and advocate for agriculture. She previously served as Senior Vice President of Science and Regulatory Affairs for CropLife America, where she was responsible for developing policies and regulations to support agriculture through crop protection. Prior to joining CropLife America, Dr. Glenn served as Managing Director of the Animal Biotechnology, Food and Agriculture Section of the Biotechnology Industry Association in Washington, DC.

Dr. Glenn holds a B.S. in animal science and a Ph.D. in ruminant nutrition from the University of Kentucky. She previously worked for the U.S. Department of Agriculture, Agricultural Research Service and the Federation of Animal Science Societies.

Born in Lincoln, Nebraska and raised in Centerville, Ohio, Dr. Glenn developed a passion for agriculture from her parents and her involvement in 4-H. She lives on a small farm in Maryland with her husband and three children, and serves on various boards for farm bureau and 4-H.

Dudley Hoskins, JD, Public Policy Counsel, National Association of State Departments of Agriculture (NASDA)

Hoskins is a native Texan and earned his undergraduate degree from Tulane University and a Juris Doctor from Texas A&M University School of Law, formerly Texas Wesleyan University School of Law. Following law school, Hoskins came to D.C. to work as legal intern for U.S. Senator David Vitter of Louisiana.

Prior to joining NASDA, Hoskins worked as the Director of Health and Regulatory Affairs of the American Horse Council and most recently served as the Manager of Regulatory Policy for RISE (Responsible Industry for a Sound Environment). Hoskins is licensed to practice law in the state of Texas.

Dan Meagher, PhD, Chief Executive Officer, Agrivida, Inc.

Mr. Meagher joins Agrivida from Novus International, where he was President of Global Animal Nutrition Solutions and responsible for global sales, marketing, animal R&D, business development, customer service, logistics & distribution and local manufacturing blend facilities. Prior to Novus, Dan was President of the Egg Products Further Processing Business Unit at MOARK, LLC, a producer and marketer of shell eggs and egg products, COO & Executive Vice President at MBA Poultry LLC, and Vice President at Purina Mills.

Lindsay Parish, PhD Infectious Disease and Vaccine Advisor, USAID

Dr. Lindsay Parish is an Infectious Disease and Vaccine Advisor at the United States Agency for International Development (USAID) where she manages livestock infectious disease, zoonotic disease, and vaccine research programs. Currently, Dr. Parish is working in a split appointment between the Research Division of the Bureau for Food Security and the Global Health Security and Development Unit in the Bureau for Global Health. Dr. Parish earned her PhD in Microbiology from the University of Alabama at Birmingham where she studied host-parasite interactions. After completing her doctoral studies, Dr. Parish accepted a three-year postdoctoral appointment at the Johns Hopkins Bloomberg School of Public Health where she studied mosquito transmission of malaria and worked on the development of transmission blocking vaccines. In 2012, she was selected as a Science and Technology Policy fellow with the America Society for the Advancement of Science (AAAS).

Jerry Pommer, Chief Commercial Officer & Vice President, Regulatory Compliance & Quality Assurance, SAB Biotherapeutics

In his current position, Mr. Pommer has been instrumental in implementing high quality animal care and use programs that have maintained USDA, NIH, and FDA regulatory compliance, and full AAALAC accreditation. He works with various committees and discussion groups that focus on animal biotechnology and actively participates in the discussions for establishing a federal regulatory framework for this technology.

He is currently a certified Professional Animal Scientist (PAS) with the Federation of Animal Science Societies (FASS). Pommer has over 30 years of work experience in animal diseases and biosecurity, development of animal models for agricultural and biomedical sciences, development of transgenic animals for human biopharmaceutical production, and animal welfare and health regulations.

Pommer received his Masters of Science Degree (MSc) in Microbiology/Veterinary Sciences from North Dakota State University. His research involved sheep respiratory diseases, which was published in several professional animal scientific journals.

Alison Van Eenennaam, PhD, Cooperative Extension Specialist Animal Genomics and Biotechnology, University of California

Dr. Alison Van Eenennaam is an Animal Genomics and Biotechnology Cooperative Extension Specialist in the Department of Animal Science at the University of California, Davis. Her publicly-funded research and outreach program focuses on the use of animal genomics and biotechnology in livestock production systems. Her current research projects include the development of genomic approaches to select for cattle that are less susceptible to disease, and applied uses of DNA-based information on commercial beef cattle operations. She also has a keen interest in making publicly-accessible educational materials and uses a variety of media to inform general public audiences about science and technology. She has provided a credentialed voice on some controversial topics including cloning and genetically engineered animals. She earned her B.S. from the University of Melbourne in Australia, and both her M.S. and Ph.D. degrees were earned from the University of California, Davis, in animal science and genetics, respectively.

Mark Walton, PhD, Vice-President, Regulatory Affairs, Yorktown Technologies

Dr. Walton is a career veteran of the plant and animal biotechnology industries and has worked as a research scientist, entrepreneur and corporate executive. Mark’s involvement in animal biotechnology began with his founding of Linkage Genetics, one of the first companies to provide DNA testing services to plant and animal breeders. Prior to joining Yorktown Technologies, Mark worked with Recombinetics, a Minnesota-based animal genetics company that utilizes state-of-the-art genome engineering methods to develop animals for the biomedical and food industries. From 2005 through 2010 Mark served as the President of ViaGen, the global leader in livestock cloning, and during his tenure was actively involved in the policies and politics of animal biotechnology. While at ViaGen he worked closely with stakeholders in the government, public and private sectors to support the FDA’s activities leading to the 2008 release of the Cloning Risk Assessment documenting the safety of cloned livestock and their offspring. Over the same period Mark and ViaGen joined the coalition of companies and public sector scientists working to clarify the process by which genetically engineered animals were to be regulated which culminated with the FDA’s release of Guidance to Industry Number 187 in 2009. Over the past several years Dr. Walton has had the opportunity to work on a variety of agricultural development projects in Africa and Asia. The opportunities to meet smallholder farmers and see firsthand the challenges facing people for whom crop loss and livestock mortality are not just an economic challenge but are potentially life threatening has reinforced his commitment to ensuring all farmers have access to the best possible technologies. In 2014 Dr. Walton worked with colleagues from around the world to bring regulators from 26 countries together for a four-day workshop on risk assessment and regulation of animal biotechnology. The actions started during the workshop are continuing and will ultimately make it possible for farmers in developing nations to benefit from advances in biotechnology.

Brigid Zeller, Manager, Legislative Affairs, Animal Health Institute

Brigid Zeller is a manager of legislative and public affairs at the Animal Health Institute, which is a trade association of firms that make veterinary medicines used to help pets and livestock live longer, healthier lives. She also serves as the Vice Chair of the Animal Agriculture Coalition. Prior to joining AHI, Zeller worked at Bayer in their government relations office, and is a graduate of The George Washington University.

Conferences and Events:

BIO Livestock Summit

H1:

Advisory Committee

Animal Biotech Summit Sponsor Company Descriptions

AAALAC International

AAALAC International provides accreditation, assessment and education services for agricultural and biomedical animal research programs. Earning accreditation assures investors, research partners, funding sources and the public of your commitment to high quality research and good science. More than 900 institutions in 39 countries have earned AAALAC accreditation.

www.aaalac.org

Avitus Group

Avitus Group is a business services company, designed to take away the headaches for business owners. They offer Payroll, Employee Compensation, Bookkeeping, Training, Recruiting, Tax Planning & Preparation, Business Valuation, HR, Benefit Offering & Administration, Employment Regulation Expertise, Risk & Safety, Business Planning, Online Marketing, and IT.

www.avitusgroup.com

Christiansen Land & Cattle, Ltd.

Christiansen Land & Cattle, Ltd, a farming & ranching organization in central South Dakota, strives for excellence in crop production and livestock management. During the past 10 years, CLC has also provided livestock management services to a biotech company in South Dakota, SAB Biotherapeutics, Inc.

Elanco

Elanco is a global innovation-driven company that develops and markets products to improve animal health and food animal production in more than 75 countries. Elanco employs more than 3,000 people worldwide, with offices in more than 40 countries, and is a division of Eli Lilly and Company.

www.elanco.com

Exemplar Genetics

Exemplar Genetics creates miniswine models of human disease. Genetically engineered miniswine models more accurately mimic human disease phenotype, making them valuable translational tools. Models include LDLR, CFTR, P53, DMD and additional rare disease models. Exemplar also creates custom models for your specific research needs.

www.exemplargenetics.com

GMO Answers

GMO Answers is an initiative committed to responding to your questions about how food is grown. Funded by the Council for Biotechnology Information’s members – BASF, Bayer CropScience, Dow, DuPont Pioneer, Monsanto and Syngenta – GMO Answers’ goal is to make information about GMOs in food and agriculture easier to access and understand.

www.gmoanswers.com

McKee, Voorhees & Sease, P.L.C.

McKee, Voorhees & Sease, PLC ("MVS") is a Des Moines, Iowa intellectual property boutique law firm. MVS provides expertise in all areas of patent, trademark and copyright law as well as intellectual property litigation. MVS fosters partnerships with our clients; inventors, entrepreneurs, artists, researchers, universities and Fortune 500 companies.

www.ipmvs.com

Novozymes

Novozymes drives industries forward by rethinking where and how biosolutions can be used. Every day, we invest in solving America’s challenges with nature. Our enzymes, microorganisms, and biopharmaceutical ingredients help produce consumer products, including biofuel, detergents, feed, and crops. The enzymes we create for animal nutrition help improve the digestion processes, making the most of the feed while keeping feed costs low. Our US locations include California, Iowa, Nebraska, North Carolina, South Dakota, Texas, Virginia, and Wisconsin. Novozymes is quoted on NASDAQ OMX Copenhagen A/S (NZYM B).

www.novozymes.com

Patterson Thuente IP

Patterson Thuente IP helps life sciences companies worldwide protect—and profit from—their ideas. Practicing in the areas of patents, trademark, IP litigation, copyright and trade secrets, international IP law, licensing, post-grant proceedings and IP portfolio management, the firm’s attorneys excel at finding strategic solutions to complex intellectual property matters.

www.ptslaw.com

Polsinelli PC

With more than 740 attorneys in 19 offices, Polsinelli serves clients nationally and internationally to provide a practical focus on client success. Polsinelli’s Intellectual Property practice handles the most complex issues facing a wide array of technology companies including bioscience, life science, and animal science companies.

www.polsinelli.com

Recombinetics

Recombinetics, the recognized global leader in the rapidly emerging field of gene editing, develops livestock products for agriculture, biomedical and regenerative medicine. The company uses a suite of technologies, including its proprietary TALEN gene editing platform, to develop products for its three market-focused subsidiaries, Acceligen, Surrogen and Regenevida.

www.recombinetics.com

SAB Biotherapeutics

SAB Biotherapeutics is a biotechnology company located in Sioux Falls, South Dakota that has developed some of the most advanced molecular genetics and antibody science in the world, and now offers a next generation technology platform in genetically engineered cattle for the production of fully human antibody therapeutics.

www.sabbiotherapeutics.com

Sanford Health

Sanford Health is an integrated health system headquartered in the Dakotas and is now the largest, rural, not-for-profit health care system in the nation with locations in 126 communities in nine states. In addition, Sanford Health is in the process of developing international clinics in Ghana, Israel, Mexico and China.

www.sanfordhealth.org

South Dakota Biotech

The South Dakota Biotech Association is the state affiliate of the Biotechnology
Industry Organization (BIO). This non-profit association is focused on the growth and development of biotechnology in South Dakota, serving member organizations, businesses, universities, service providers and state-wide economic development entities to expand the bioscience industry.

www.sdbio.org

South Dakota Governor's Office of Economic Development

South Dakota is a top state ranking state for doing business and a great place for companies in the bioscience industry. No other state is able to offer the superb business climate, educated workforce and collaboration opportunities that you will find in South Dakota. At the Governor’s Office of Economic Development, we work to expand primary job opportunities in South Dakota and we work with local EDCs to expand and diversify the state’s economy, as well as administer a variety of financing programs.

www.sdreadytowork.com

South Dakota State University

South Dakota State University is the state’s largest, most comprehensive school of higher education. SDSU offers more than 175 majors, minors and specializations, including 29 master’s degrees, 13 Ph.D. and two professional programs. The work of the university is carried out on a residential campus in Brookings, at sites in Sioux Falls, Pierre and Rapid City, and through Extension and AES sites across the state.

www.sdstate.edu

Trans Ova Genetics

Trans Ova Genetics is internationally recognized as a provider of industry-leading reproductive technologies including embryo transfer, in-vitro fertilization (IVF), sexed-semen, genetic preservation and ViaGen cloning technology. These “tools” are available for breeders looking to achieve specific reproductive goals. Trans Ova offers an integrated system of regional centers, satellite stations and on-farm application of reproductive technologies.

www.transova.com

Zoetis

Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostics products and genetic tests and supported by a range of services.

www.zoetis.com

Conferences and Events:

BIO Livestock Summit

H1:

Sponsor Company Descriptions

Hotel and Venue

Venue Address

Bethesda Marriott
5151 Pooks Hill Road
Bethesda, Maryland 20814
Phone: +1-301-897-9400

Reservations

Book online HERE.

To book over the phone, the Bethesda Marriott can be contacted direct at +1-301-897-9400 or +1-800-228-9290. Request the group block “BIO Animal Biotech Summit.”

The cutoff date for BIO’s negotiated rate has passed (August 30), but the Bethesda Marriott will still accept reservations based on availability, and at prevailing rates, as long as possible.

Sleeping Room Rates Starting at:

Standard King or Double : $209.00 USD

All rates are subject to applicable state and local taxes (currently 13%) in effect at the time of check out.

Conferences and Events:

BIO Livestock Summit

H1:

Hotel and Venue

About Animal Biotech Summit

The concept of One Health recognizes the interdependence of human, animal and environmental health. The Animal Biotech Summit will provide an opportunity to learn about how and why the One Health approach is required for addressing some of the greatest threats to human health. It is difficult to imagine how we will meet current and future challenges in the absence of this interdisciplinary point of view and approach to problem-solving. The Animal Biotech Summit will provide broad overviews of some of the animal health, biomedical research, biotherapeutics, food safety and security, and environmental applications of biotechnology. The sessions will feature presentations on the relationship of the One Health approach to:

Sustainability in animal production
Farm animal health and welfare
Food safety, quality and security
Vector-borne diseases
Emerging infectious diseases
Animal models of human diseases
Environmental disruptions and health
Regulatory issues
Trade impacts
Public acceptance
Incentives for new product development

WHO SHOULD ATTEND?

Industry, academic and government scientists in biomedical, veterinary, wildlife and agricultural fields
Pharmaceutical and agricultural executives in R&D, regulatory, and international affairs
Government officials, regulators and policymakers
Investors in innovative pharmaceutical and agricultural technologies
Advocacy groups representing the interests of human health and animal agriculture

Between 2010 and 2014, BIO hosted three Livestock Biotech Summits that focused on the use of genetically engineered animals in agriculture and medicine. This year we are broadening the scope of the conference to encompass the application of many biotechnologies, including genetic engineering, to animals in order to understand, identify and solve problems where animal, human and environmental health issues intersect.

WHY ATTEND?

To manage and reduce One Health risks with biotechnology we need:

A holistic view of human, animal and ecosystem interfaces
Interdisciplinary collaborations and new partnerships
An appreciation of the complex interactions among humans, animals and the environments they live in
Access to every available tool for identifying and solving problems
Sustained support from federal agencies, research institutions, policymakers and the public

The Animal Biotech Summit will provide an opportunity to initiate much-needed conversations, create new networks and break down barriers that obstruct successful implementation of One Health.

For general information, contact Adrianne Massey at amassey@bio.org or call 202.962.9238.

Conferences and Events:

BIO Livestock Summit

H1:

About Animal Biotech Summit

BIO Highlights the Value of Intellectual Property for Animal Biotechnology at the 2014 Livestock Biotech Summit

Submitted by ckennedy on Wed, 2014-09-10 14:37

SDSU Offers Tours of Animal Research Facilities to Kick Off BIO’s 2014 Livestock Biotech Summit

Submitted by ckennedy on Wed, 2014-09-03 10:01

Dr. Richard Raymond to be Keynote Speaker for 2014 BIO Livestock Biotech Summit

Submitted by ckennedy on Thu, 2014-08-21 12:16

2014 Sponsor Company Descriptions

AAALAC International

Avitus Group

Christiansen Land & Cattle, Ltd.

Elanco

Exemplar Genetics

GMO Answers

McKee, Voorhees & Sease, P.L.C.

Novozymes

Patterson Thuente IP

http://www.ptslaw.com/

Polsinelli PC

http://www.polsinelli.com/

Recombinetics

SAB Biotherapeutics

Sanford Health

South Dakota Biotech

South Dakota Governor's Office of Economic Development

South Dakota State University

http://www.sdstate.edu/

Trans Ova Genetics

Zoetis

Conferences and Events:

BIO Livestock Summit

Events at LBS

Tour at Trans Ova Genetics

Trans Ova Genetics focuses on the application of genetic and reproductive technologies to meet the world’s needs for enhancing animal protein production. They began providing assisted reproductive technology services to progressive cattlemen and women in 1980. Today they offer a toolbox of bovine ART services including ET (embryo transfer), IVF (in vitro fertilization), SS (sexed semen options) and cloning. The cloning services are provided to multiple species through a wholly owned subsidiary, ViaGen. In addition, they have been involved in the production of genetically modified animals for biopharmaceutical projects for over 15 years.

The Trans Ova Genetics tour will include a program that describes how these services are used by livestock producers today as well as a walking tour of the laboratories for ET, IVF and cloning. In addition, a tour of the donor cow, recipient cow and calving management systems will be provided. Hors d'oeuvres will be provided including beef from animals produced using cloning technology.

Visit the USGS Earth Resources Observation and Science (EROS) Center

Earth Resources Observation and Science (EROS) Center is a remotely sensed data management, systems development, and research field center for the U.S. Geological Survey's(USGS) Climate and Land Use Change Mission Area. The USGS is a bureau of the U.S. Department of the Interior. EROS opened in the early 1970's with a handful of employees and the largest mainframe computer in the State of South Dakota. It currently houses one of the largest computer complexes in the Department of the Interior. EROS has approximately 600 government and contractor employees.

We encourage you to take a tour of EROS to learn how it began. View a model of the Landsat 8 satellite and learn about how Earth-observing satellites work. This satellite imagery from around the world is used to monitor change over time, and you’ll see numerous examples of slow and subtle changes as well as rapid and devastating ones.

Conferences and Events:

BIO Livestock Summit

first
previous
1
2
3
4
5
next
last

ARGUS LEADER– 09.13.16

THE LEDGER– 08.29.16

THE WALL STREET JOURNAL – 08.02.16

THE CONVERSATION – 07.27.16

AQUABOUNTY: GMO PIONEER – 07.27.16

ONE HEALTH COMMISSION – 07.13.16 | 11:00AM - 12:00PM EDT

Upcoming Webinar: Antimicrobial Resistance in the Environment (Part 2 of 2)

ONE HEALTH COMMISSION – 07.06.16 | 11:00AM - 12:00PM EDT

Upcoming Webinar: One Health and the Politics of Antibiotic Resistance (Part 1 of 2)

CARIBOU BIOSCIENCES – 05.18.16

BIGSTORY.AP.ORG – 05.17.16

NATURE.COM – 05.03.16

AAVMC.ORG - 04.13.2016

THE NEW YORK TIMES - 01.30.2016

SCIENCE INSIDER - 12.18.2015

THE NEW YORK TIMES - 11.19.2015

MOTHER JONES - SEPTEMBER/OCTOBER 2015

POPULAR SCIENCE - 07.06.2015

GEN EXCLUSIVES- 01.2.2015

Tom Carrato, JD, Member & Principal Consultant, Creative Biotech Solutions, LLC

Chase Crawford, DVM, Director, Antimicrobial Resistance Initiative

Bernadette Dunham, DVM, PhD, Visiting Professor at Milken Institute School of Public Health, George Washington University

Cassie Edgar, JD, Associate General Counsel, IP & Director, R&D Strategy, Genus Plc.

Kipp Erickson, PhD, Vice President, Technology & Commercialization, Intrexon Corporation

Barbara Glenn, PhD, Chief Executive Officer, National Association of State Departments of Agriculture (NASDA)

Dudley Hoskins, JD, Public Policy Counsel, National Association of State Departments of Agriculture (NASDA)

Dan Meagher, PhD, Chief Executive Officer, Agrivida, Inc.

Lindsay Parish, PhD Infectious Disease and Vaccine Advisor, USAID

Jerry Pommer, Chief Commercial Officer & Vice President, Regulatory Compliance & Quality Assurance, SAB Biotherapeutics

Alison Van Eenennaam, PhD, Cooperative Extension Specialist Animal Genomics and Biotechnology, University of California

Mark Walton, PhD, Vice-President, Regulatory Affairs, Yorktown Technologies

Brigid Zeller, Manager, Legislative Affairs, Animal Health Institute

AAALAC International

Avitus Group

Christiansen Land & Cattle, Ltd.

Elanco

Exemplar Genetics

GMO Answers

McKee, Voorhees & Sease, P.L.C.

Novozymes

Patterson Thuente IP

Polsinelli PC

Recombinetics

SAB Biotherapeutics

Sanford Health

South Dakota Biotech

South Dakota Governor's Office of Economic Development

South Dakota State University

Trans Ova Genetics

Zoetis

Venue Address

Reservations

WHO SHOULD ATTEND?

WHY ATTEND?

AAALAC International

Avitus Group

Christiansen Land & Cattle, Ltd.

Elanco

Exemplar Genetics

GMO Answers

McKee, Voorhees & Sease, P.L.C.

Novozymes

Patterson Thuente IP

Polsinelli PC

Recombinetics

SAB Biotherapeutics

Sanford Health

South Dakota Biotech

South Dakota Governor's Office of Economic Development

South Dakota State University

Trans Ova Genetics

Zoetis

Tour at Trans Ova Genetics

Visit the USGS Earth Resources Observation and Science (EROS) Center